Investing carries serious risks, including partial or total loss of capital. Please read the Key Investment Information Sheet and the Risk factors and login before investing.
Presscuff 3A
€301,000
total amount raised in round
244%
- Eligible for a tax reduction
Benjamin De Vlam
COO
Dr. Benjamin De Vlam is the COO of Presscuff. He is responsible for the day-to-day management of Presscuff.
He is a physician by training at the University of Antwerp.
Evert Van Meeuwen
CFO
Evert Van Meeuwen, CFA, is Presscuff's chief financial officer.
He has a background in investments and business development.
Emiel Suijs
Founder
Emiel Suijs is the inventor of the Presscuff. Throughout his working career, he has worked as a head nurse in the Intensive Care Unit of the VUB.
Peter Frederickx
Advisor
Peter Frederickx helps Presscuff achieve the necessary certification. He has years of experience as a lead auditor and has been helping companies meet the necessary MDR standards for many years now.
TAX SHELTER 45%
Investments in this company benefit from a 45% personal income tax reduction. Read more…A remaining amount of €264,000 is available for the Tax Shelter benefit.
Raise summary
| Crowd investments | €61,000 |
| Committed by others | €240,000 |
| Amount raised | €301,000 |
| Minimum round | €25,000 |
| Maximum round | €2,500,000 |
| Shares in the company (total round) | 22.341% |
| Pre-money valuation | €8,690,000 |
| Post-money valuation min. | €8,715,000 |
| Post-money valuation max. | €11,190,000 |